2
Clinical Trials associated with DWP-09031A dose block-randomized, double-blind, placebo-controlled, single/multiple dosing, dose-escalation clinical phase 1 trial to investigate the safety, tolerability, and pharmacokinetics of DWP09031 after oral administration in healthy male subjects
Start Date18 Jan 2012 |
Sponsor / Collaborator- |
A Dose Block-randomized, Double-blind, Placebo-controlled, Single/Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of orally administrated DWP09031 in healthy male volunteers.
100 Clinical Results associated with DWP-09031
100 Translational Medicine associated with DWP-09031
100 Patents (Medical) associated with DWP-09031
100 Deals associated with DWP-09031